Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

Roche is committing $50 billion over the next five years for new research and development sites across the country, and the ...

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, ...

Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...

The big pharma joined several of its peers in committing to invest billions of dollars in new and expanded manufacturing ...

The investment would go toward high-tech research and development sites and new manufacturing facilities in Indiana, ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T-cell-targeted ...

Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new ...

The White House has not yet clarified the extent of tariffs on pharmaceuticals, meanwhile, Swiss giant Roche has announced a ...

Roche has picked up a CE Mark approval in the EU for an artificial intelligence algorithm that can help doctors decide whether patients presenting with acute chest pain are having a heart attack.